GENERAL INDEX 



743 



Epinephrin, as cause of arterial hyper- 

 tension in nephritis, iv, 404.-* 



assaying of, methods for, i, 36. 



chromaffin substance, i, 68. 



concentration of, in blood plasma of 

 suprarenal veins, ii, 151. 



control of, i, 168. 



data concerning physiological ac- 

 tion of, ii, 307. 



demonstrated in blood of the adrenal 

 veins, ii, 127. 



by frog perfusion method (in cats 



and rabbits), ii, 128. 



by rabbit intestine segment meth- 

 od (in dogs), ii, 129. 



.depressor effects of, ii, 197. 



destruction of, in body, ii, 193. 



differential effects of, in various or- 

 gans, ii, 203. 



on circulation of the brain, ii, 221. 



on circulation of the intestine, ii, 



217. 

 on circulation of the kidney, ii, 



214. 



on circulation of the limb, ii, 205. 

 on circulation of the liver, ii, 208. 



on circulation of the spleen, ii, 

 212. 



on heart, ii, 222. 



pulmonary circulation, ii, 225. 



distribution of, ii, 93. 



as between the cortex and me- 

 dulla, ii, 190. 



effects of, on arterial system, ii, 188. 

 on heart, ii, 189. 



on metabolism, body temperature, 

 iii, 781. 



carbohydrate, iii, 781. 



catalase, iii, 781. 



growth, iii, 782. 



mineral, iii, 782. 



protein, iii, 782. 



total, iii, 780. 



water, iii, 781. 



on the circulation, ii, 203. 



of the brain, ii, 221. 



of the heart, ii, 222. 



of the intestine, ii, 217. 



of the kidney, ii, 214. 



of the limb, ii, -205. 



of the liver, ii, 208. 



pulmonary, ii, 225. 



of the spleen, ii, 212. 



on vonous pressure, ii, 228. 



toxic, ii, 251. 



empiric therapy with, and arsenical 

 antisyphilitic preparations, i, 140. 



diseases, i, 140. 



Epinephrin, empiric therapy with, un- 

 desirable results and contradictions, 

 i, 141. 



-functions of, in body, ii, 151. 



-history of (Abel), ii, 80, 81. 



- immunity to, i, 31. 



indispensability of, ii, 161. 



induced by asphyxia, ii, 174. 



by excitement, ii, 175. 



by sensory stimulation, evidence 



of, ii, 172. 



influence of, on metabolism, general, 

 ii, 246. 



sugar, ii, 246. 



injection of, pharmacodynamic ef- 

 fects following, i, 16. 



in ophthalmology, ii, 804. 



isolation and investigation of, i, 68. 



location of action of, ii, 252. 



gangliar mechanism, ii, 253. 



myoneural junctions, ii, 252. 



locus of stimulation by, ii, 192. 



nature of, i, 8. 



organotherapy of, in acute suprare- 

 nal insufficiency (acute hypoadre- 

 nia), i, 132. 



in Addison's disease, i, 131. 



in circulatory failure of infec- 

 tious diseases, i, 132. 



in collapse of infectious diseases, 

 i, 133. 



in Erb's myasthenia, i, 134. 



in suprarenal insufficiency, func- 

 tional (hypoadrenia), i, 134. 



persistence of, in blood-stream, ii, 

 193. 



pharmacodynamic action of, i, 124, 

 167. 



antispastic, i, 138. 



circulatory action, i, 124. 

 -in the blood, i, 126. 



on absorption and fat in body, i, 

 128. 



on excretion, i, 129. 



on habituation, i, 130. 



on kidneys, i, 127. 



on metabolism, i, 128. 



on nervous system, non-vegeta- 

 tive, i, 128. 



on poisoning, acute and chronic, 

 i, 130. 



on secretions, i, 127. 



on suprarenal glycosuria, i, 127. 



on temperature, i, 128. 



on the alimentary canal, i, 126. 



on the eye, i, 127. 



on the respiratory system, i, 126. 

 on the uterus, i, 126. 



